Additionally, it is essential to mention that MAPK is recognised as an inducer of inflammation in DCM, as it amplifies NF-κB expression, hence intensifying DCM by enhancing inflammation and the generation of pro-inflammatory cytokines (Rezaee et al., 2024). The gene discussed is NFKB1; the disease is familial dilated cardiomyopathy.